CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism

Paavo Pietarinen, Perttu Koskenvesa, Judith Klievink, Kimmo Porkka, Mikko Niemi, Satu Mustjoki

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Original languageEnglish
JournalBlood
Volume128
Issue number22
Number of pages4
ISSN0006-4971
Publication statusPublished - 2 Dec 2016
Event58th Annual Meeting and Exposition of the American-Society-of-Hematology - San Diego, Canada
Duration: 3 Dec 20166 Dec 2016

Cite this

@article{97a0b4b3b6774173bfdb5278cd22d37c,
title = "CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism",
author = "Paavo Pietarinen and Perttu Koskenvesa and Judith Klievink and Kimmo Porkka and Mikko Niemi and Satu Mustjoki",
year = "2016",
month = "12",
day = "2",
language = "English",
volume = "128",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "22",

}

CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism. / Pietarinen, Paavo; Koskenvesa, Perttu; Klievink, Judith; Porkka, Kimmo; Niemi, Mikko; Mustjoki, Satu.

In: Blood, Vol. 128, No. 22, 02.12.2016.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

TY - JOUR

T1 - CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism

AU - Pietarinen, Paavo

AU - Koskenvesa, Perttu

AU - Klievink, Judith

AU - Porkka, Kimmo

AU - Niemi, Mikko

AU - Mustjoki, Satu

PY - 2016/12/2

Y1 - 2016/12/2

M3 - Meeting Abstract

VL - 128

JO - Blood

JF - Blood

SN - 0006-4971

IS - 22

ER -